Mbco Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-12-2024
- Paid Up Capital ₹ 0.40 M
as on 08-12-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.90 M
as on 08-12-2024
- Satisfied Charges ₹ 1.67 M
as on 08-12-2024
- Revenue 0.91%
(FY 2022)
- Profit -4.17%
(FY 2022)
- Ebitda -0.52%
(FY 2022)
- Net Worth 10.39%
(FY 2022)
- Total Assets 10.11%
(FY 2022)
About Mbco Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹2.90 M. The company has closed loans amounting to ₹1.67 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Mishra and Mamta Mishra serve as directors at the Company.
- CIN/LLPIN
U24304DL2019PTC347180
- Company No.
347180
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Mbco Lifesciences Private Limited offer?
Mbco Lifesciences Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Antidiabetic Medicine, Juices, Soups & Soft Drinks, Instant Drink Mix, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Respiratory System Drugs, Anti Asthma Drug.
Who are the key members and board of directors at Mbco Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Mishra  | Director | 12-Mar-2019 | Current |
| Mamta Mishra | Director | 09-Nov-2020 | Current |
Financial Performance of Mbco Lifesciences.
Mbco Lifesciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.91% increase. The company also saw a slight decrease in profitability, with a 4.17% decrease in profit. The company's net worth Soared by an impressive increase of 10.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mbco Lifesciences?
Unlock access to Mbco Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Feb 2023 | ₹2.90 M | Open |
Tamilnad Mercantile Bank Limited Creation Date: 30 Nov 2021 | ₹0.23 M | Satisfied |
Tamilnad Mercantile Bank Limited Creation Date: 31 Dec 2019 | ₹1.45 M | Satisfied |
How Many Employees Work at Mbco Lifesciences?
Unlock and access historical data on people associated with Mbco Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mbco Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mbco Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
